Study to Evaluate the Tolerance and Safety of a Peptide-based Enteral Formula with Partially Hydrolyzed Guar Gum (PHGG)
Clinical trial NCT04516213 · COMPLETED
Trial details
- NCT number
- NCT04516213
- Sponsor
- Société des Produits Nestlé (SPN)
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2020-02-28
- Primary completion
- 2021-06-01
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.